Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbimazole versus placebo for cardiovascular risk markers in subclinical hyperthyroidism
ISRCTN13184358Phase 4Completed
- Sponsor
- Tan Tock Seng Hospital
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in subclinical hyperthyroidism comparing Carbimazole with Placebo (2 arms). Primary endpoints: Circulating endothelial progenitor cells, Circulating endothelial cells and 5 more. Started Dec 2012; status: completed.
02
Drugs
carbimazole
03
Conditions
subclinical hyperthyroidism
Beyond the preview
Go deeper on ISRCTN13184358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13184358.